Episode #109: Brian Schardt of ChatGPT Portfolio- Exploring the Potential of AI Trading
Confessions Of A Market Maker
00:00
Confessions of a Market Maker
There's a lot of really cool development with stem cells going on. I've actually been to different stem cell places in South America, just to receive treatment. And so there's a bunch of stem cell companies that are publicly traded. One of them is sell you sell you Larity, CELU. They used to be like, you know, 10 bucks a share and they dropped all the way to under a dollar. But they recently received a $45 million contract. chat TPT seems to suggest it's a very, very, very positive thing for the stock.
Transcript
Play full episode
